The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The neuroprotective effects of caffeine in neurodegenerative diseases
Open accessAbstract
Summary: Caffeine is the most widely used psychostimulant in Western countries, with antioxidant, anti‐inflammatory and anti‐apoptotic properties. In Alzheimer's disease (AD), caffeine is beneficial in both men and women, in humans and animals. Similar effects of caffeine were observed in men with Parkinson's disease (PD); however, the effect of caffeine in female PD patients is controversial due to caffeine's competition with estrogen for the estrogen‐metabolizing enzyme,CYP 1A2. Studies conducted in animal models of amyotrophic lateral sclerosis (ALS)showed protective effects of A 2A R antagonism. A study found caffeine to be associated with earlier age of onset of Huntington's disease (HD) at intakes >190 mg/d, but studies in animal models have found equivocal results. Caffeine is protective in AD and PD at dosages equivalent to 3‐5 mg/kg. However, further research is needed to investigate the effects of caffeine on PD in women. As well, the effects of caffeine in ALS,HD and Machado‐Joseph disease need to be further investigated. Caffeine's most salient mechanisms of action relevant to neurodegenerative diseases need to be further explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Modulation of Genetic Associations with Serum Urate Levels by Body-Mass-Index in Humans
Huffman, J. E., Albrecht, E., Teumer, A., Mangino, M., Kapur, K., Johnson, T., Kutalik, Z., Pirastu, N., Pistis, G., Lopez, L. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119752 · Cited by 1,227
Ryanodine Receptor Calcium Release Channels
Fill, M., & Copello, J. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00013.2002 · Cited by 1,099
Calcium dyshomeostasis and intracellular signalling in alzheimer's disease
LaFerla, F. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn960 · Cited by 978
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Effects of caffeine on human behavior
Smith, A. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00096-0 · Cited by 741
Regulation of Cardiac L-Type Calcium Channels by Protein Kinase A and Protein Kinase C
Kamp, T. J., & Hell, J. W. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1095 · Cited by 606
Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen, J.-F., Xu, K., Petzer, J. P., Staal, R., Xu, Y.-H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N., & Schwarzschild, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 606
Association of Coffee Drinking with Total and Cause-Specific Mortality
Freedman, N. D., Park, Y., Abnet, C. C., Hollenbeck, A. R., & Sinha, R. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112010 · Cited by 596
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490
Arendash, G. W., Schleif, W., Rezai-Zadeh, K., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 457
A Calcium-Dependent Feedback Mechanism Participates in Shaping Single NMDA Miniature EPSCs
Umemiya, M., Chen, N., Raymond, L. A., & Murphy, T. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00001.2001 · Cited by 450
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
Boswell‐Smith, V., Spina, D., & Page, C. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706495 · Cited by 405
Checkoway, H., Powers, K., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., & Swanson, P. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.8.732 · Cited by 369
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Caffeine as an Antioxidant: Inhibition of Lipid Peroxidation Induced by Reactive Oxygen Species
Devasagayam, T. P. A., Kamat, J. P., Mohan, H., & Kesavan, P. C. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00040-5 · Cited by 331
Tsutsui, S., Schnermann, J., Noorbakhsh, F., Henry, S., Yong, V. W., Winston, B. W., Warren, K., & Power, C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 323
Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease
Koch, P., Breuer, P., Peitz, M., Jungverdorben, J., Kesavan, J., Poppe, D., Doerr, J., Ladewig, J., Mertens, J., Tüting, T., et al. (2011) · Nature · doi:10.1038/nature10671 · Cited by 303
Caffeine for treatment of Parkinson disease: A randomized controlled trial
Postuma, R. B., Lang, A. E., Munhoz, R. P., Charland, K., Pelletier, A., Moscovich, M., Filla, L., Zanatta, D., Rios Romenets, S., Altman, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318263570d · Cited by 298
Caffeine Content of Specialty Coffees
McCusker, R. R., Goldberger, B. A., & Cone, E. J. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.7.520 · Cited by 295
Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers
Bell, D. G., & McLellan, T. M. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00187.2002 · Cited by 288
Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
The Coffee and Caffeine Genetics Consortium, Cornelis, M. C., Byrne, E. M., Esko, T., Nalls, M. A., Ganna, A., Paynter, N., Monda, K. L., Amin, N., Fischer, K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.107 · Cited by 287
Coffee and tea consumption and the risk of Parkinson's disease
Hu, G., Bidel, S., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2007) · Movement Disorders · doi:10.1002/mds.21706 · Cited by 280
Ghotbi, R., Christensen, M., Roh, H.-K., Ingelman-Sundberg, M., Aklillu, E., & Bertilsson, L. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0288-2 · Cited by 264
Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 254
(1988) · PubMed · Cited by 250
Plant alkaloids as drug leads for Alzheimer's disease
Ng, Y. P., Or, T. C. T., & Ip, N. Y. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.018 · Cited by 234
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease
Qi, H., & Li, S. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12123 · Cited by 233
van Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228
The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans
Garrett, B. E., & Griffiths, R. R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00435-2 · Cited by 224
Ha, A. D., & Jankovic, J. (2012) · Movement Disorders · doi:10.1002/mds.23959 · Cited by 223
Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi-Albedi, F., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218
Caffeine and Coffee as Therapeutics Against Alzheimer's Disease
Arendash, G. W., & Cao, C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091249 · Cited by 201
Adenosine receptor targets for pain
Sawynok, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.031 · Cited by 199
Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms
Tassaneeyakul, W., Birkett, D. J., McManus, M. E., Tassaneeyakul, W., Veronese, M. E., Andersson, T., Tukey, R. H., & Miners, J. O. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90304-2 · Cited by 198
Ullah, F., Ali, T., Ullah, N., & Kim, M. O. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.001 · Cited by 190
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
Laurent, C., Burnouf, S., Ferry, B., Batalha, V. L., Coelho, J. E., Baqi, Y., Malik, E., Mariciniak, E., Parrot, S., Van der Jeugd, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2014.151 · Cited by 188
Caffeine and risk of Parkinson’s disease in a large cohort of men and women
Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185
Kong, H., Jones, P. P., Koop, A., Zhang, L., Duff, H. J., & Chen, S. R. W. (2008) · Biochemical Journal · doi:10.1042/bj20080489 · Cited by 184
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R., Freedman, N. D., Hollenbeck, A. R., Blair, A., & Chen, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr451 · Cited by 170
Purinergic signalling in brain ischemia
Pedata, F., Dettori, I., Coppi, E., Melani, A., Fusco, I., Corradetti, R., & Pugliese, A. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.007 · Cited by 165
Shi, D., Nikodijević, O., Jacobson, K. A., & Daly, J. W. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733753 · Cited by 163
Prediger, R. D. S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091459 · Cited by 160
Qosa, H., Abuznait, A. H., Hill, R. A., & Kaddoumi, A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120319 · Cited by 159
Prasanthi, J. R. P., Dasari, B., Marwarha, G., Larson, T., Chen, X., Geiger, J. D., & Ghribi, O. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.007 · Cited by 158
Nakaso, K., Ito, S., & Nakashima, K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.034 · Cited by 152
Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease
Sato, A., Terata, K., Miura, H., Toyama, K., Loberiza, F. R., Hatoum, O. A., Saito, T., Sakuma, I., & Gutterman, D. D. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00575.2004 · Cited by 150
Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J., Ascherio, A., Dluzen, D. E., & Schwarzschild, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-05.2006 · Cited by 146
Adenosine: setting the stage for plasticity
Dias, R. B., Rombo, D. M., Ribeiro, J. A., Henley, J. M., & Sebastião, A. M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.12.003 · Cited by 145
Xu, K., Xu, Y.-H., Chen, J., & Schwarzschild, M. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.020 · Cited by 140
Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
Hong Van, B., Metzger, S., Portal, E., Deyle, C., Rieß, O., & Nguyen, H. P. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-1 · Cited by 137
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
Blum, D. L., Hourez, R., Galas, M., Popoli, P., & Schiffmann, S. N. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00411-3 · Cited by 135
Cholesterol, APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba
Hall, K., Murrell, J., Ogunniyi, A., Deeg, M., Baiyewu, O., Gao, S., Gureje, O., Dickens, J., Evans, R., Smith-Gamble, V., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194507.39504.17 · Cited by 128
Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women
Pollock, B. G., Wylie, M. E., STACK, J. A., Sorisio, D. A., Thompson, D. S., Kirshner, M. A., Folan, M., & Condifer, K. A. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008560 · Cited by 121
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
Chen, X., Wu, J., Lvovskaya, S., Herndon, E., Supnet, C. B., & Борисович, Б. И. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-81 · Cited by 107
Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
Chu, Y.-F., Chang, W.-H., Black, R. M., Liu, J.-R., Sompol, P., Chen, Y., Wei, H., Zhao, Q., & Cheng, I. H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.04.148 · Cited by 106
Josse, A. R., Costa, L. A. D., Campos, H., & El‐Sohemy, A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.038794 · Cited by 101
Begas, E., Kouvaras, E., Tsakalof, A. K., Παπακώστα, Σ., & Asprodini, E. (2007) · Biomedical Chromatography · doi:10.1002/bmc.736 · Cited by 98
Pain in Amyotrophic Lateral Sclerosis: A Neglected Aspect of Disease
Handy, C. R., Krudy, C. A., Boulis, N. M., & Federici, T. (2011) · Neurology Research International · doi:10.1155/2011/403808 · Cited by 93
Sonsalla, P. K., Wong, L., Harris, S. L., Richardson, J. R., Khobahy, I., Li, W., Gadad, B. S., & German, D. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.022 · Cited by 92
Gonçalves, N., Simões, A. T., Cunha, R. A., & de Almeida, L. P. (2013) · Annals of Neurology · doi:10.1002/ana.23866 · Cited by 92
Dragicevic, N., Delic, V., Cao, C., Copes, N., Lin, X., Mamcarz, M., Wang, L., Arendash, G. W., & Bradshaw, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.018 · Cited by 86
Zeitlin, R., Patel, S., Burgess, S., Arendash, G. W., & Echeverría, V. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.036 · Cited by 85
Halldner, L., Ådén, U., Dahlberg, V., Johansson, B. A., Ledent, C. A., & Fredholm, B. B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.014 · Cited by 84
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
Pedata, F., Pugliese, A. M., Coppi, E., Dettori, I., Maraula, G., Cellai, L., & Melani, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/805198 · Cited by 80
Li, X., Liu, H., Fischhaber, P. L., & Tang, T.-S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.06.004 · Cited by 79
Involvement of Human CYP1A Isoenzymes in the Metabolism and Drug Interactions of Riluzole In Vitro
Sanderink, G.-J., Bournique, B., Stevens, J. C., Petry, M., & Martinet, M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36944-7 · Cited by 78
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
Liu, J., Supnet, C. B., Sun, S., Zhang, H., Good, L. B., Александровна, П. Е., & Борисович, Б. И. (2014) · Channels · doi:10.4161/chan.27471 · Cited by 77
Does acute caffeine ingestion alter brain metabolism in young adults?
Xu, F., Liu, P., Pekar, J. J., & Lu, H. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.01.046 · Cited by 75
Yoshimura, H. (2005) · Current Neuropharmacology · doi:10.2174/157015905774322543 · Cited by 74
Association between caffeine intake and age at onset in Huntington's disease
Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.013 · Cited by 73
Alfinito, P. D., Wang, S.-P., Manzino, L., Rijhsinghani, S., Zeevalk, G. D., & Sonsalla, P. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10982.2003 · Cited by 72
Han, K., Jia, N., Ji, L., Li, Y., & Min, L. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1601 · Cited by 72
Coffee, CYP1A2 genotype and risk of myocardial infarction
El‐Sohemy, A., Cornelis, M. C., Kabagambe, E. K., & Campos, H. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0043-4 · Cited by 70
Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
Kim, Y. S., Kwak, S. M., & Myung, S. (2015) · Neuroepidemiology · doi:10.1159/000371710 · Cited by 69
Feeling smart: Effects of caffeine and glucose on cognition, mood and self-judgment
Ullrich, S., de Vries, Y. C., Kühn, S., Repantis, D., Dresler, M., & Ohla, K. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.08.028 · Cited by 62
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
Basurto‐Islas, G., Blanchard, J., Tung, Y. C., Fernández, J. R., Voronkov, M. V., Stock, M. B., Zhang, S., Stock, J. B., & Iqbal, K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.012 · Cited by 62
A Disruption Mechanism of the Molecular Clock in a MPTP Mouse Model of Parkinson’s Disease
Hayashi, A., Matsunaga, N., Okazaki, H., Kakimoto, K., Kimura, Y., Azuma, H., Ikeda, E., Shiba, T., Yamato, M., Yamada, K., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8214-x · Cited by 57
Ng, S. K., Higashimori, H., Tolman, M., & Yang, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.004 · Cited by 57
Giunta, S., Andriolo, V., & Castorina, A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.07.009 · Cited by 53
Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13 C NMR study
Bagga, P., Chugani, A. N., & Patel, A. B. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.006 · Cited by 50
Mohamed, R. A., Agha, A. M., Abdel‐Rahman, A. A., & Nassar, N. N. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.059 · Cited by 49
Variation in Caffeine Concentration in Single Coffee Beans
Fox, G. P., Wu, A. C., Liang, Y., & Force, L. E. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4011388 · Cited by 48
Mievis, S., Blum, D. L., & Ledent, C. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.021 · Cited by 48
Fondell, E., O’Reilly, É. J., Fitzgerald, K. C., Falcone, G. J., Kolonel, L. N., Park, Y., Gapstur, S. M., & Ascherio, A. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1020813 · Cited by 47
Moro, S., Deflorian, F., Spalluto, G., Pastorin, G., Cacciari, B., Kim, S., & Jacobson, K. A. (2003) · Chemical Communications · doi:10.1039/b303439a · Cited by 45
Ghoneim, F. M., Khalaf, H. A., Elsamanoudy, A. Z., El‐khair, S. M. A., Helaly, A. M. N., Mahmoud, E.-H. M., & Elshafey, S. H. (2015) · PubMed · Cited by 38
Nascimento, F., Pousinha, P. A., Correia, A. M., Gomes, R., Sebastião, A. M., & Ribeiro, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104081 · Cited by 37
Carelli‐Alinovi, C., Ficarra, S., Russo, A. M., Giunta, E., Barreca, D., Galtieri, A., Misiti, F., & Tellone, E. (2015) · Biochimie · doi:10.1016/j.biochi.2015.11.022 · Cited by 37
Mishra, J., & Kumar, A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.07.006 · Cited by 36
Nascimento, F., Sebastião, A. M., & Ribeiro, J. A. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9465-4 · Cited by 30
Mohamed, R. A., Agha, A. M., & Nassar, N. N. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0640-x · Cited by 28
Kumar, P. M., Paing, S. S. T., Li, H., Pavanni, R., Yuen, Y., Zhao, Y., & Tan, E. K. (2015) · Scientific Reports · doi:10.1038/srep15492 · Cited by 28
Reproductive factors and Parkinson's disease risk in Danish women
Greene, N., Lassen, C. F., Rugbjerg, K., & Ritz, B. R. (2014) · European Journal of Neurology · doi:10.1111/ene.12450 · Cited by 28
Arita, R., Yanagi, Y., Honda, N., Maeda, S., Maeda, K., Kuchiba, A., Yamaguchi, T., Yanagihara, Y., Suzuki, H., & Amano, S. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.11.033 · Cited by 22
Molecular Vibration-Activity Relationship in the Agonism of Adenosine Receptors
Chee, H. K., & Oh, S. J. (2013) · Genomics & Informatics · doi:10.5808/gi.2013.11.4.282 · Cited by 19
Moghimi, E., Solomon, J. A., Gianforcaro, A., & Hamadeh, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126355 · Cited by 13
Self-citationDobson, K. L., Jackson, C. L. M., Balakrishnan, S., & Bellamy, T. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125974 · Cited by 8
Caffeine and alzheimer's disease
Rajendran, P., Bhatt, A., Manthuruthil, S., & Pericherla, S. (2013) · Cited by 2
Cited by
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illes, P., Di Virgilio, F., Ulrich, H., Semyanov, A., Verkhratsky, A., Sperlagh, B., Yu, S.-G., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 489
Health Benefits and Chemical Composition of Matcha Green Tea: A Review
Kochman, J., Jakubczyk, K., Antoniewicz, J., Mruk, H., & Janda, K. (2020) · Molecules · doi:10.3390/molecules26010085 · Cited by 328
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
Sinyor, B., Mineo, J., & Ochner, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200171 · Cited by 120
Metadata
- Authors
- Kolahdouzan, M., & Hamadeh, M. J.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2017-03-20
- Volume
- 23
- Issue
- 4
- Pages
- 272-290
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2601931132
- Cited by
- 302
- References
- 108
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.